RT Journal Article
SR Electronic
T1 Excess weight mediates changes in HDL pool that reduce cholesterol efflux capacity and increase antioxidant activity
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19002899
DO 10.1101/19002899
A1 Jose Carlos de Lima-Junior
A1 Vitor W.M. Virginio
A1 Filipe A. Moura
A1 Adriana Bertolami
A1 Marcelo Bertolami
A1 Otavio R Coelho-Filho
A1 Ilaria Zanotti
A1 Wilson Nadruz
A1 Eliana Cotta de Faria
A1 Luiz Sergio F. de Carvalho
A1 Andrei C Sposito
YR 2019
UL http://medrxiv.org/content/early/2019/07/24/19002899.abstract
AB Objective Obesity-related decline in high-density lipoprotein (HDL) functions such as cholesterol efflux capacity (CEC) has supported the notion that this lipoprotein dysfunction may contribute for atherogenesis among obese patients. Besides, potentially other HDL protective actions may be affected with weight gain and these changes may occur even before the obesity range.Methods Lipid profile, body mass index (BMI), biochemical measurements, and carotid intima-media thickness (cIMT) were obtained in this cross-sectional study with 899 asymptomatic individuals. HDL functions were measured in a subgroup (n=101).Results Individuals with increased HDL-C had an attenuated increase in cIMT with elevation of BMI. CEC, HDL-C, HDL size and HDL-antioxidant activity were negatively associated with cIMT. BMI was inversely associated with HDL-mediated inhibition of platelet aggregation and CEC, but surprisingly it was directly associated with the antioxidant activity. Thus, even in non-obese, non-diabetic individuals, increased BMI is associated with a wide change in protective functions of HDL, reducing CEC and increasing antioxidant activity. In these subjects, decreased HDL concentration, size or function are related to increased atherosclerotic burden.Conclusion Our findings demonstrate that in non-obese, non-diabetic individuals, the increasing values of BMI are associated with impaired protective functions of HDL and concomitant increase in atherosclerotic burden.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT02487615 and NCT02106013Funding StatementThe study was supported by São Paulo Research Foundation (FAPESP 2010/00201-8 and FAPESP 2006/60585-9 and CNPq (471380/2008-13). JCLJ was supported by a doctoral grant from Coordination for the Improvement of Higher-Level Education Personnel (Capes grant number PROEX0092045). NBP was supported by a doctoral grant (number 2012/01645-2) from the Foundation for Research Support of the State of Sao Paulo (FAPESP). Prof Sposito was supported by a fellowship grant of productivity in research from the National Council for Scientific and Technological Development (CNPq) (grant number 301465/2017-7).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.YesI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.YesThe datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.ALTalanine aminotransferaseApoA-Iapolipoprotein A-IASTaspartate aminotransferaseCEcholesteryl esterCECCholesterol efflux capacityCETPcholesteryl ester transfer proteincIMTcarotid intima-media thicknessFCfree cholesterolHLhepatic lipaseHOMA2 % βHomeostasis model assessment 2 of beta-cell functionHOMA2-IRHomeostasis model assessment 2 of insulin resistanceHOMA2 %SHomeostasis model assessment 2 of insulin sensitivityHUVEChuman umbilical vein endothelial cellsLCATLecithin–cholesterol acyltransferase activityPLphospholipidisLPLLipoprotein lipasePONparaoxonaseTCtotal cholesterolPLTPphospholipids transfer proteinVCAM-1vascular cell adhesion molecule-1